Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.94 USD | +1.29% | -1.97% | +1.53% |
08/05 | Syndax Pharmaceuticals Q1 Net Loss Widens | MT |
08/05 | Transcript : Syndax Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.53% | 1.84B | |
+29.77% | 49.18B | |
+1.00% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.99% | 18.71B | |
+8.22% | 13.26B | |
+32.41% | 12.32B | |
-1.62% | 11.99B |
- Stock Market
- Equities
- SNDX Stock
- News Syndax Pharmaceuticals, Inc.
- Guggenheim Initiates Syndax Pharmaceuticals With Buy Rating, $40 Price Target